🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (October 1, 2011) – Revue de presse (1er octobre 2011)


Fighting Cervical Cancer With Vinegar and Ingenuity
Nurses using the new procedure, developed by experts at the Johns
Hopkins medical school in the 1990s and endorsed last year by the
World Health Organization, brush vinegar on a woman’s cervix. It makes
precancerous spots turn white. They can then be immediately frozen off
with a metal probe cooled by a tank of carbon dioxide, available from
any Coca-Cola bottling plant..
By Donald G. McNeil Jr.In The New York Times
http://www.nytimes.com/2011/09/27/health/27cancer.html

Breast cancer treatment change could save time, money
Women facing radiation treatments after breast cancer surgery could
complete the therapy in half the time, saving patients time and money
and returning them more quickly to normal life if a major national
study delivers on expectations.
By Patricia Anstett. In USAToday
http://yourlife.usatoday.com/health/medical/breastcancer/story/2011-09-26/Breast-cancer-treatment-could-change-with-new-study/50553068/1

“50/50”: Half-Life
Identifying the cellular origins of breast cancer might lead to
earlier diagnosis and more efficient management of the disease. New
research led by Charlotte Kuperwasser of Tufts University School of
Medicine (TUSM) has determined that common forms of breast cancer
originate from breast cells known as luminal epithelial cells while
rarer forms of breast cancer, such as metaplastic carcinomas,
originate from basal epithelial cell types. The study was published
online ahead of print this week in PNAS Early Edition as part of its
breast cancer special feature.
By Richard Brody. In The New Yorker (blog)
http://www.newyorker.com/online/blogs/movies/2011/09/5050-half-life.html

Study Says Big Tobacco Covered Up Info on Cancer Risk
A new study claims that tobacco companies knew for years that
cigarette smoke contained dangerous and potentially deadly
radioactivity but purposefully didn't let the public know.
U.S. News & World Report
http://health.usnews.com/health-news/managing-your-healthcare/cancer/articles/2011/09/30/study-says-big-tobacco-covered-up-info-on-cancer-risk

Diabetes again linked to colon cancer risk: study
People with diabetes have a somewhat increased risk of colon cancer,
an international study said -- but the reasons for the connection, and
what should be done about it, remain unclear.
By Elaine Lies. Reuters
http://www.reuters.com/article/2011/09/29/us-diabetes-idUSTRE78S11820110929

Breast cancer drug could add five months
A new breast cancer drug could hold back the growth of cancer by five
months while reducing dangerous side effects, early trial results
suggest. By Nick Collins. In Telegraph.co.uk
http://www.telegraph.co.uk/health/healthnews/8787803/Breast-cancer-drug-could-add-five-months.html

Chemotherapy Safe to Give During Pregnancy
A cancer diagnosis can be devastating, but is even more traumatic when
the patient is pregnant. A new study offers some reassurance to
pregnant patients and their physicians.
By Roxanne Nelson. Medscape
http://www.medscape.com/viewarticle/750446

Cancer Care's “Culture of Excess”‎
You probably didn’t need an expert panel of researchers to tell you
that the cost of treating cancer is spiraling out of control. But one
did, and what that panel has to say is eye-opening, even when you’ve
heard it all before.
By Jessica Wapner. In PLoS Blogs (blog)
http://blogs.plos.org/workinprogress/2011/09/27/cancer-cares-culture-of-excess/

Cancer drug too expensive for NHS
A chemotherapy drug that extends the lives of men with advanced
prostate cancer is too expensive for use on the NHS, according to
draft guidance. The National Institute for Health and Clinical
Excellence (Nice) said cabazitaxel (Jevtana), in combination with
prednisone or prednisolone was not cost-effective as a second line
treatment after hormone therapy.
By Jane Kirby. In The Independant
http://www.independent.co.uk/life-style/health-and-families/health-news/cancer-drug-too-expensive-for-nhs-2363449.html

ECCO-ESMO: Hypercalcemia of Cancer Stalled By Antibody
Hypercalcemia of malignancy occurred half as often in cancer patients
treated with denosumab (Xgeva) than in those given zoledronic acid
(Zometa), analysis of data from two large clinical trials showed.
By Charles Bankhead. MedPage Today
http://www.medpagetoday.com/MeetingCoverage/ECCO-ESMO/28818

Cancer du sein : Octobre rose lancé sur fond de polémique sur le
dépistage‎
L'édition 2011 d'Octobre rose, mois de mobilisation en faveur du
dépistage du cancer du sein, a été lancée mercredi, sur fond de
polémique sur le risque de surdiagnostic, alors que le programme
national de dépistage marque le pas. Par Annie HAUTEFEUILLE. AFP
http://www.google.com/hostednews/afp/article/ALeqM5itOFjHZXJAPMGsWWaXLhJlvIqzrw?docId=CNG.56046555f9ecb55dd1a98c39237f77be.b1

50/50: guérison par la dérision
Il est important, il est même urgent, de rire dans la vie. L’humour
n’est pas qu’un art, qu’une industrie; il s’agit, répète-t-on souvent,
d’une véritable thérapie. 50/50, comédie dramatique ou drame comique,
participe de cette belle idée, fort répandue, qu’il vaut toujours
mieux en rire qu’en pleurer. Et réussit, parfois à moitié, le pari
d’amuser et de divertir avec un sujet plutôt rébarbatif: le cancer.
Par Aleksi K. Lepage. Dans Cyberpresse
http://moncinema.cyberpresse.ca/nouvelles-et-critiques/critiques/critique-cinema/15742-i5050i-guerison-par-la-derision.html

Les hommes ont plus de lésions au côlon que les femmes, selon une
étude
Les hommes ont davantage de lésions au côlon que les femmes à tout âge
ce qui laisse penser qu'ils présentent un risque accru de cancer
colorectal, selon une étude effectuée en Autriche publiée mardi aux
Etats-Unis.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5hN5xu5Zex_I9ei7YIVb5fiilDT2w?docId=CNG.eb14ca866f188104c325faf8b34504a0.771


L'inhibition de protéines ralentirait les métastases osseuses
Des chercheurs en France ont découvert comment les métastases osseuses
peuvent être retardées. Lors du récent congrès européen
multidisciplinaire sur le cancer tenu cette année à Stockholm, en
Suède, le professeur Stéphane Oudard, du département d'oncologie à
l'hôpital George Pompidou en France, faisait remarquer que
l'inhibition d'une protéine impliquée dans le métabolisme osseux était
essentielle au retardement de métastases osseuse, une occurrence
fréquente chez les hommes chez qui une forme particulière de cancer de
la prostate est diagnostiquée.
CORDIS Nouvelles
http://cordis.europa.eu/fetch?CALLER=FR_NEWS&ACTION=D&SESSION=&RCN=33851










Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen  (10/2011)